PB
Parallel Bio
Organization
A biotechnology company developing high-throughput human biology and drug-discovery platforms, including organoid-based experimental systems.
What experts have said about Parallel Bio
2 statements · 2 positive
Parallel Bio received FDA approval to bypass animal trials using organoid testing.
“they got FDA approval to skip animal trials.”
Open the episode · Recursive's $670M Bet on Self-Improving AI, Sonnet 5.5 Hits 70%, Elon Co-Leads Pentagon Push | EP #299Listen at 17:31
Parallel Bio’s organoid responses are more predictive of human drug interactions than animal tests.
“how those organoids react to different drugs and toxicity testing and so on, is actually more predictive of how those drugs will interact in real human bodies.”
Open the episode · Recursive's $670M Bet on Self-Improving AI, Sonnet 5.5 Hits 70%, Elon Co-Leads Pentagon Push | EP #299Listen at 18:00
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
